Zhejiang Anglikang Pharmaceutical Co Ltd Class A
Zhejiang AngLiKang Pharmaceutical CO.,LTD., a pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases. The company also offers products in the areas of anti-infection, antihypertensive, digestive system, central nervous diseases, and respiratory preparations. The company was founded in 2001 and is based in … Read more
Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.062x
Based on the latest financial reports, Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) has a cash flow conversion efficiency ratio of 0.062x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥112.57 Million) by net assets (CN¥1.83 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Anglikang Pharmaceutical Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Zhejiang Anglikang Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Anglikang Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shanxi Guoxin Energy Co Ltd A
SHG:600617
|
0.151x |
|
Global Industrial Co
NYSE:GIC
|
0.072x |
|
Shenzhen Sea Star Technology
SHE:002137
|
0.031x |
|
Fitipower Integrated Technology Inc
TW:4961
|
0.004x |
|
Inland Real Estate Income Trust Inc
PINK:INRE
|
0.037x |
|
Penyao Environmental Protection Co Ltd Class A
SHE:300664
|
0.023x |
|
Monro Inc
F:MR2
|
0.029x |
|
MRV Engenharia e Participações S.A
SA:MRVE3
|
0.014x |
Annual Cash Flow Conversion Efficiency for Zhejiang Anglikang Pharmaceutical Co Ltd Class A (2014–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Anglikang Pharmaceutical Co Ltd Class A from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.80 Billion | CN¥253.60 Million | 0.141x | -6.69% |
| 2023-12-31 | CN¥1.83 Billion | CN¥276.91 Million | 0.151x | +34.66% |
| 2022-12-31 | CN¥1.65 Billion | CN¥184.75 Million | 0.112x | -16.25% |
| 2021-12-31 | CN¥1.47 Billion | CN¥197.65 Million | 0.134x | -7.03% |
| 2020-12-31 | CN¥1.38 Billion | CN¥198.61 Million | 0.144x | -31.38% |
| 2019-12-31 | CN¥1.02 Billion | CN¥213.49 Million | 0.210x | +52.63% |
| 2018-12-31 | CN¥970.93 Million | CN¥133.61 Million | 0.138x | -71.99% |
| 2017-12-31 | CN¥394.37 Million | CN¥193.77 Million | 0.491x | +13.50% |
| 2016-12-31 | CN¥327.43 Million | CN¥141.74 Million | 0.433x | -17.47% |
| 2015-12-31 | CN¥264.20 Million | CN¥138.59 Million | 0.525x | +125.68% |
| 2014-12-31 | CN¥217.08 Million | CN¥50.46 Million | 0.232x | -- |